Pediatr. praxi. 2022;23(3):181-184 | DOI: 10.36290/ped.2022.039
Recurrent aphthous stomatitis (RAS) is the most common chronic oral mucosal lesion affecting up to 25% of population. The diagnosis is based on well-defined clinical characteristics but the precise aetiology and pathogenesis remains unclear. The treatment of RAS should be based on identification and control of possible predisposing factors. A wide range of topical medicaments is available as antiseptics, anti-inflammatory drugs and corticosteroids. The systemic treatment is indicated in patients with continuous and aggressive manifestation, what is extremely rare in children. The present article provides a review of the current concept and knowledge of the aetiology, pathogenesis, and management of RAS in paediatric population.
Published: June 10, 2022 Show citation